Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Sources Sought opportunity was posted on March 29, 2013. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

COLLECTION OF DATA ON DOSES TO MEMBERS OF THE PUBLIC EXPOSED TO PATIENTS TREATED WITH IODINE-131

Closed
RES-13-092Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 541712
New
DIBBS
PISTON, INNER TUBE, A
Solicitation # SPE7M4-27-T-1466
Solicitation SPE7M4-27-T-1466 is a request for quotations issued by the DLA Weapons Support Fluid Handling Division for the procurement of 12,000 units of Piston, Inner Tube, A, identified by NSN 1710-01-478-1536 and Boeing part number 74A430839-2003. This is a restricted source item requiring engineering source approval by the government design control activity. The contract specifies a delivery timeframe of 154 days after receipt of order, with a need ship date of April 6, 2027, and an original required delivery date of March 6, 2028. Shipping is established as FOB Origin, with the final destination being the DLA Distribution DDSP New Cumberland Facility in Pennsylvania. The contract mandates strict adherence to quality and technical standards, including the DLA Master List of Technical and Quality Requirements, with specific prohibitions against the use of Class I ozone-depleting chemicals. Packaging must comply with ASTM D3951 and RP001, while marking and labeling must follow MIL-STD-129 and RQ017 for bare item marking. Inspection and acceptance will occur at the destination per FAR 52.246-2, utilizing sampling methods such as MIL-STD-1916 or ASQ H1331. Administrative requirements include the use of the Wide Area WorkFlow system for invoicing and compliance with DFARS 252.225-7001 regarding the Buy American and Balance of Payments Program.
DLA WEAPONS SUPPORT FLUID HANDLING DIVISION

POSTED

5 days ago

DEADLINE

in 8 days

General Info

Agency

N/A

NAICS

541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)

Place of Performance

Not specified

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseClosed
Posted

Sources Sought

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyN/A
Contacts2 people available
OfficeN/A
Organization / Agency
N/A
Office AddressN/A
Contacts
Claudia G. MelgarContract Specialist
Aracelis Perez-OrtizContract Specialist

Full Description

Show more
SOURCES SOUGHT NOTICE THE U. S. NUCLEAR REGULATORY COMMISSION (NRC) is issuing this Sources Sought Synopsis as a means of conducting market research or as a market survey to determine the availability and potential technical capability of the business community to provide all management, supervision, administration, and labor for the COLLECTION OF DATA ON DOSES TO MEMBERS OF THE PUBLIC EXPOSED TO PATIENTS TREATED WITH IODINE-131: 1) Measure External Doses to Selected Members of the Public; 2) Measure Internal Doses to Selected Members of the Public; 3) Time and Motion Study; 4) Analysis of Data and Final Report; and 5) Technical Support. Services are to be provided to the NRC in Rockville, Maryland. The applicable North American Industry Classification System (NAICS) code assigned to this procurement is 541712. THERE IS NO SOLICITATION AT THIS TIME. This request for capability information does not constitute a request for proposal; submission of any information in response to this market survey is purely voluntary; the Government assumes no financial responsibility for any costs incurred. The purpose of this announcement is to provide potential sources the opportunity to submit information regarding their capabilities to perform work for the NRC free of conflict of interest (COI). For information on NRC COI regulations, visit NRC Acquisition Regulation Subpart 2009.5 (http://www.nrc.gov/about-nrc/contracting/48cfr-ch20.html). All interested parties, including all categories of small businesses (small businesses, small disadvantaged businesses, 8(a) firms, women-owned small businesses, service-disabled veteran-owned small businesses, and HUBZone small businesses) are invited to submit a response. The capabilities package submitted by a vendor should demonstrate the firm's ability, capability, and responsibility to perform the principal components of work listed below. The package should also include past performance/experience regarding projects of similar scope listing the project title, general description, the dollar value of the contract, and name of the company, agency, or government entity for which the work was performed. Organizations responding to this market survey should keep in mind that only focused and pertinent information is requested. If significant subcontracting or teaming is anticipated in order to deliver technical capability, organizations should address the administrative and management structure of such arrangements. Organizations responding to this market survey should keep in mind that only focused and pertinent information is requested. Submission of additional materials such as glossy brochures or videos is discouraged. BACKGROUND: Radioactive iodine, mainly the isotope Iodine-131, is used in the diagnosis and treatment of several medical conditions, the primary ones in the present context being treatment of hyperthyroidism and thyroid cancer following thyroidectomy. The importance of these conditions arises from the fact that their treatment protocols generally call for administration of relatively large doses of Iodine-131, and such patients therefore pose the greatest potential for exposure of others. Patients are often released from the hospital following treatment if they meet the release conditions specified in the Nuclear Regulatory Commission's (NRC) Code of Federal Regulations (CFR) Title 10, Part 35.75, "Release of individuals containing unsealed byproduct material or implants containing byproduct material." The basic criterion underlying the release conditions is that "the total effective dose equivalent to any other individual from exposure to the released individual is not likely to exceed 5 mSv (0.5 rem)." MANDATORY QUALIFYING CRITERIA: The contractor shall have established an "institutional review board" Title 21 of the Code of Federal Regulations Part 50, which is a panel of experts that approves clinical trials and is required by the federal regulations. MARKET RESEARCH QUESTIONS: If your organization has the potential capacity to perform these contract services, please provide the following information: 1) Organization name, address, email address, Web site address and telephone number. 2) What size is your organization with respect to NAICS code 541712 (i.e. "small" or "other than small")? If your organization is a small business under the aforementioned NAICS code, what type of small business (i.e. small disadvantaged business, woman-owned small business, economically disadvantaged woman-owned small business, veteran-owned small business, service-disabled veteran-owned small business, 8(a), or HUBZone small business? Specify all that apply. 3) Although no geographic restriction is anticipated, if responding organizations are located outside the Washington Metropolitan area (Maryland, Virginia, and the District of Columbia), indicate how the organization would coordinate with the NRC program office located in Rockville, Maryland to provide the support services. 4) Does your organization have experience providing dose measurements and analysis on human subjects? If so, please list and describe those contracts (contract number, contract type, contract value, description of supplies and services included in the scope, period of performance, etc.) and indicate your organization's role (prime contractor, first tier subcontractor, and/or supplier). 5) Indicate whether your organization provides any radiological research on existing Federal Government contracts (i.e., GSA Federal Supply Schedule contracts or Government-wide Acquisition Contracts) that the NRC could order from, providing the contract number(s) and indicate what is currently available for ordering from each contract. 6) Has your company worked for any of the licensee's regulated (http://www.nrc.gov/reading-rm/doc-collections/cfr/) by the NRC in the past year? 7) Has your company previously brought to the NRC any potential organizational conflict of interest issues with NRC? If so, how were they resolved? Interested firms responding to this Sources Sought Synopsis are encouraged to structure capability statements in the order of the area of consideration noted above. All capability statements sent in response to this notice must be submitted electronically, via e-mail, to Claudia Melgar, at Claudia.Melgar@nrc.gov, in either Microsoft Word or Adobe Portable Document Format (PDF), within eighteen (18) calendar days from the date of publication of this notice. This market survey is being conducted through the FedBizOpps to reach the widest possible audience and to gather current market information. ADDITIONAL INFORMATION: No current incumbent contractor. DISCLAIMER AND NOTES: Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's potential capability and capacity to perform the subject work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a pre-solicitation synopsis and solicitation may be published in Federal Business Opportunities. However, responses to this notice will not be considered adequate responses to a solicitation.

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS